• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

46.7000 USD 0.3000 0.65%

As of 20:04:07 ET on 09/18/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 46.6000 High - Low: 46.7100 - 46.2320 Primary Exchange: NYSE Arca
Volume: 33,979 52-Week Range: 33.0400 - 48.1200 Beta vs DZOTR: 0.9988

ETF Chart for PBE

No chart data available.
  • PBE:US 46.7000
  • 1D
  • 1M
  • 1Y
46.4000
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-09-18) 46.6956
Assets (M) (on 2014-09-18) 396.9129
Shares out (M) 8.50
Market Cap (M) 396.95
% Premium 0.01
Average 52-Week % Premium 0.0205
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.50%

Performance for PBE

1-Month +1.08% 1-Year +32.10%
3-Month +6.50% 3-Year +33.56%
Year To Date +26.71% 5-Year +22.50%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 09/18/2014
Name Position Value % of Total
Regeneron Pharmaceuticals Inc 57,197 20,747,640 5.232%
Amgen Inc 143,843 20,428,583 5.152%
Pharmacyclics Inc 161,177 20,142,290 5.079%
Sigma-Aldrich Corp 192,777 19,913,864 5.022%
Illumina Inc 111,780 19,887,898 5.015%
Gilead Sciences Inc 186,362 19,741,327 4.978%
Biogen Idec Inc 58,445 19,286,266 4.863%
Alexion Pharmaceuticals Inc 118,429 19,133,389 4.825%
United Therapeutics Corp 92,809 12,151,482 3.064%
Medivation Inc 119,830 12,094,442 3.050%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil